Assignee
CSL BEHRING GENE THERAPY INC
US·5 granted patents·6 pending applications·3 citations·filing 2018–2023
Top patents by PatentIndex Score
11 records- 0182US10961537B2Compositions and methods for treating beta-hemoglobinopathiesCSL BEHRING GENE THERAPY INC·Filed 2018·Granted Mar 30, 2021·2 cites·27 claims
- 0279US11299752B2Bio-production of lentiviral vectorsCSL BEHRING GENE THERAPY INC·Filed 2018·Granted Apr 12, 2022·1 cites·2 claims
- 0376US2024043845A1Compositions and methods for treating beta-hemoglobinopathiesCSL BEHRING GENE THERAPY INC·Filed 2023·Application pending·0 cites
- 0469US11795461B2Compositions and methods for treating beta-hemoglobinopathiesCSL BEHRING GENE THERAPY INC·Filed 2021·Granted Oct 24, 2023·0 cites·21 claims
- 0569US2022315950A1Bio-production of lentiviral vectorsCSL BEHRING GENE THERAPY INC·Filed 2022·Application pending·0 cites
- 0668US11213548B2Modulatable switch for selection of donor modified cellsCSL BEHRING GENE THERAPY INC·Filed 2019·Granted Jan 4, 2022·0 cites·25 claims
- 0766US2022016176A1Dual vector for inhibition of human immunodeficiency virusCSL BEHRING GENE THERAPY INC·Filed 2021·Application pending·0 cites
- 0864US2022072046A1Modulatable switch for selection of donor modified cellsCSL BEHRING GENE THERAPY INC·Filed 2021·Application pending·0 cites
- 0961US2021032627A1Gene therapeutic for the treatment of hiv and uses thereofCSL BEHRING GENE THERAPY INC·Filed 2020·Application pending·0 cites
- 1055US11008630B2Methods for discriminating between HIV-1 and lentiviral vectorsCSL BEHRING GENE THERAPY INC·Filed 2019·Granted May 18, 2021·0 cites·9 claims
- 1152US2021238632A1Vector production in serum free mediaCSL BEHRING GENE THERAPY INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CSL BEHRING GENE THERAPY INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →